About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
A year into Covid-related shutdowns, we are seeing a host of devastating impacts unrelated to the illness itself. One of these is hunger.
Food insecurity – lack of consistent access to sufficient, nutritious food – was a major public-health concern before the pandemic. Climate change’s extended droughts, destructive fires and storms, and rising waters are wiping out resources in many areas, notably India and Africa. Poverty is another contributing factor, particularly in cities with “food deserts” where it is hard to find fresh fruit and vegetables and other healthy options. (Interestingly, the World Bank reports that “children who are properly nourished during the first 1,000 days of their lives are 33% more likely to escape poverty as adults.”)
Covid-19 is now, by some measures, the leading cause of death in the U.S., surpassing heart disease. Yet not only is heart disease not going away, its rates are expected to increase due to Covid; as the American Heart Association recently reported, Covid’s influence “will directly and indirectly impact rates of cardiovascular disease prevalence and deaths for years to come.”
While coronavirus research at the Weizmann Institute of Science continues full speed ahead, so does critical work on heart disease. February is American Heart Month, so we’d like to share current Weizmann Institute research on this most celebrated organ.
Our mental health is always important, but more so than ever during these challenging times. Between the ongoing COVID pandemic, economic insecurity, social turmoil, and the like, rates of anxiety and depression are skyrocketing. How to cope? And why do we experience mental health issues in the first place?
As with the coronavirus, the answers are found in science.
The Weizmann Institute’s renowned neuroscientists do more than study the brain; they investigate how this most mysterious of organs responds to the world, processes our experiences, plays a role in emotional response, consolidates memories, becomes ill, and more. Our scientists also seek to develop effective medications and treatments. As Prof. Alon Chen – a renowned expert in neuropsychiatry and Weizmann Institute president – says, “I strongly believe that when we identify the mechanisms in the brain, we can use them to develop better ways to treat these conditions.”
Just as COVID-19 is still advancing, so is the research of Weizmann Institute scientists as they develop ways to identify, predict, treat, and prevent the illness. One particularly innovative researcher is Prof. Noam Sobel.
A neurobiologist who is a world leader in olfaction research, Prof. Sobel works in the Weizmann tradition of following his curiosity as he harnesses the sense of smell to fight COVID. His previous studies have shown that our olfactory system has powers that many of us would never have imagined; he has used the sense of smell – our most ancient sense – to quantify the smell of fear; shed light on social miscues in autism and diagnose the condition; help locked-in, vegetative patients communicate; reveal subconscious reactions to the opposite sex; and much more.
Even in 2020, with all we know about health and nutrition, heart disease is still the leading cause of death in America, accounting for one in four mortalities. Fortunately, the Weizmann Institute of Science is taking multiple approaches to understanding and treating this too-common killer. February is American Heart Month – and we’d love to share our very latest research with you.
While there are several vital heart-related projects underway at the Institute, the lab of leading researcher Prof. Eldad Tzahor recently made a significant breakthrough: discovering that a non-toxic dye actually helps repair damaged heart tissue, such as the scarring that occurs after a heart attack.
Immunotherapies, which harness the immune system to fight disease, are revolutionizing treatments for many types of cancer. Having made significant breakthroughs in the field, Weizmann Institute of Science researchers are now exploring ways to apply immunotherapy to conditions other than cancer, including neurodegenerative diseases like Alzheimer’s. Prof. Ido Amit of the Department of Immunology is advancing this research by developing sophisticated tools and technologies to investigate the immune system’s role in neurodegenerative diseases.
Weizmann Institute researchers from across the disciplines are pursuing topics in neuroscience, approaching this crucial field from a number of angles. That’s because understanding our brains – in both health and disease – benefits everyone on this planet.
From Alzheimer’s to autism, Parkinson’s to mental health, memory to aging and beyond, here are just some of the Institute’s neuroscience advances over just the past year:
There is a reason that a puzzle piece is the symbol of autism spectrum disorder (ASD). Despite all the research, despite the advances, ASD continues to be an enigma. What causes it? Can it be diagnosed earlier? What are the differences between an autistic and a neurotypical brain?
One field of research – the role of the sense of smell – is producing surprising results that could lead to means of early diagnosis and intervention, as well as shed light on the misreading of social cues that is so common in autism.
Issue 52 of Weizmann Views presents the research of Prof. Michal Schwartz, who pioneered the field of neuroimmunity. She is working on methods for treating Alzheimer’s and other age-related diseases.